Wordt geladen...
Dasatinib promotes TRAIL‐mediated apoptosis by upregulating CHOP‐dependent death receptor 5 in gastric cancer
Dasatinib, a tyrosine kinase inhibitor, has been approved for first‐line treatment of leukemia and has also been evaluated for use in numerous other cancers. However, its role in gastric cancer (GC) remains unclear. Therefore, the aim of this study was to investigate how dasatinib suppresses the gro...
Bewaard in:
| Gepubliceerd in: | FEBS Open Bio |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5929929/ https://ncbi.nlm.nih.gov/pubmed/29744288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12404 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|